Trial intelligence / Profile preview

Zegerid vs Prilosec OTC Pharmacodynamics

NCT00765206Phase 3Completed

Sponsor
Bayer
Start
May 2008
Primary completion
Aug 2008
Modality
Small Molecules
01

Overview

A Phase 3 trial of omeprazole + sodium bicarbonate in gastroesophageal reflux disease (GERD), sponsored by Bayer. Started May 2008; status: completed.

02

Drugs

omeprazole + sodium bicarbonate
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT00765206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00765206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call